Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients

Details for Australian Patent Application No. 2004216472 (hide)

Owner Chiesi Farmaceutici S.p.A.

Inventors Pastore, Fiorella; Razzetti, Roberta

Agent Lord and Company

Pub. Number AU-B-2004216472

PCT Pub. Number WO2004/075896

Priority 03004184.2 27.02.03 EP

Filing date 27 February 2004

Wipo publication date 10 September 2004

Acceptance publication date 6 August 2009

International Classifications

A61K 31/47 (2006.01) - Quinolines

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

Event Publications

15 September 2005 PCT application entered the National Phase

  PCT publication WO2004/075896 Priority application(s): WO2004/075896

6 August 2009 Application Accepted

  Published as AU-B-2004216472

3 December 2009 Standard Patent Sealed

22 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004216473-Manganese based organometallic complexes, pharmaceutical compositions and dietetic products

2004216458-Pharmaceutical compositions for nasal delivery